×
For best experience we recommend to activate Javascript in your browser.
NG2 antibody (AA 559-776)
This anti-NG2 antibody is a Mouse Monoclonal antibody detecting NG2 in WB, IHC, IP and ICC. Suitable for Human.
Quick Overview for NG2 antibody (AA 559-776) (ABIN7614225)
Target
See all NG2 (MCSP) Antibodies
NG2 (MCSP)
(Melanoma Associated Chondroitin Sulfate Proteoglycan (MCSP))
Reactivity
All reactivities for NG2 antibodies
Human
Host
All hosts for NG2 antibodies
Mouse
Clonality
All clonalities for NG2 antibodies
Monoclonal
Conjugate
All conjugates for NG2 antibodies
This NG2 antibody is un-conjugated
Application
All applications for NG2 antibodies
Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
Clone
6#
Product Details anti-NG2 Antibody
(hide)
Binding Specificity
All epitopes for NG2 antibodies
AA 559-776
Purpose
Chondroitin Sulfate Proteoglycan 4 (CSPG4) Monoclonal Antibody
Sequence
His559~Pro776
Characteristics
The Chondroitin Sulfate Proteoglycan 4 (CSPG4) Monoclonal Antibody (Species: Human) has been validated for the following applications: WB, IHC, ICC, IP.
Purification
Protein A + Protein G affinity chromatography
Isotype
IgG1 kappa
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
1 mg/mL
Buffer
PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Expiry Date
12 months
Target Details for NG2
(hide)
Target
NG2 (MCSP)
(Melanoma Associated Chondroitin Sulfate Proteoglycan (MCSP))
Alternative Name
CSPG4
Gene ID
1464
UniProt
Q6UVK1
Pathways
Glycosaminoglycan Metabolic Process
Recently viewed
(hide)
Chat with us , powered by LiveChat